Atossa Therapeutics Inc. (ATOS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Atossa Therapeutics Inc.

    NASDAQ: ATOS · Real-Time Price · USD
    1.01
    0.09 (9.78%)
    At close: Oct 03, 2025, 3:59 PM
    1.03
    1.98%
    Pre-market: Oct 06, 2025, 06:34 AM EDT

    Atossa Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.66 -3.69 -2.49 -9.08
    PEG Ratio
    		 0.28 -0.26 -0.15 0.10
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.66 1.22 0.57 1.35
    P/FCF Ratio
    		 -5.65 -5.29K -3.23 -11.35
    P/OCF Ratio
    		 -5.65 -5.3K -3.23 -11.36
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 14.99 17.33 20.29 44.35
    Current Ratio
    		 14.99 17.61 21.23 45.18
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.36 -0.33 -0.23 -0.15
    Return on Assets
    		 -0.33 -0.31 -0.22 -0.15
    Return on Invested Capital
    		 -0.39 -0.34 -0.23 -0.15
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist